June 25th, 2023

Exact Sciences Corporation (Nasdaq: EXAS) was maintained with a Buy rating by Canaccord Genuity, who raised the price target from $92 to $115.  On Friday, $EXAS closed at $92.62, indicating a potential upside of $22.38 or 24.16% based on the . Read more

June 25th, 2023

The results from a phase 3 clinical trial evaluating Eli Lilly and Company's (NYSE: LLY) tirzepatide (10 mg and 15 mg) for chronic weight management in individuals with obesity or overweight and type 2 diabetes demonstrated superior weight reduction . Read more

June 25th, 2023

Several companies are expected to report their financial results on Wednesday, June 28, including: BlackBerry Limited (NYSE: BB), a global leader in secure communication and software solutions, is scheduled to release its first-quarter fiscal year. Read more

June 25th, 2023

DexCom, Inc. (Nasdaq: DXCM) is making significant strides in its financial performance, leading the company to update its year-end 2025 revenue targets. With strong performance in the first two years of the target period, DexCom now expects to achiev. Read more

June 25th, 2023

Pfizer Inc. (NYSE: PFE) has received FDA approval for LITFULO (ritlecitinib), an oral treatment for severe alopecia areata in individuals aged 12 and above. LITFULO, which is expected to be available in the coming weeks, is the first and only FDA-app. Read more

June 24th, 2023

The U.S. Food and Drug Administration (FDA) has released its first draft guidance on conducting clinical trials with psychedelic drugs for potential medical treatment. Published on June 23, 2023, the guidance aims to provide researchers with importan. Read more

June 24th, 2023

Several companies are scheduled to report their financial results on Wednesday, June 28, including: Micron Technology, Inc. (Nasdaq: MU), a leading semiconductor company, is scheduled to report its third-quarter fiscal 2023 financial results after. Read more

June 24th, 2023

Meta Platforms, Inc. (Nasdaq: META), a prominent social media company, had its price target raised from $255 to $315 by Roth MKM, maintaining its Buy rating.  With Friday's closing price at $288.73, the adjusted price target implies a potenti. Read more

June 24th, 2023

On Tuesday, June 27, several companies are expected to report their financial results. Here are some details Walgreens Boots Alliance, Inc. (Nasdaq: WBA), a leading pharmacy retail company, is set to announce its fiscal 2023 third-quarter results . Read more

June 24th, 2023

President Joe Biden issued a statement on the anniversary of Dobbs v. Jackson Women's Health Organization, expressing concern over the Supreme Court's decision to overturn Roe v. Wade, which has had significant negative consequences. He highlighte. Read more